Stepped Care for Obesity
Trial Summary
What is the purpose of this trial?
This study is a 3-group, parallel design, randomized controlled trial (RCT) in approximately 258 adults with obesity that will investigate whether a 16-week behavioral weight loss treatment and a 52-week stepped-care digital health intervention can improve the maintenance of a ≥ 5% weight loss. 16-week run-in (Phase 1). To qualify for randomization, participants must lose ≥ 5% of initial weight in the 16-week run-in. This loss will be achieved with the provision of weekly-group lifestyle counseling, which includes a partial meal replacement diet. 52-week randomized trial of 3 weight loss maintenance strategies (Phase 2): Participants who have achieved ≥ 5% weight loss during Phase 1 will be randomly assigned to 1 of 3 groups: 1. Participants in the Usual Care group will be emailed monthly educational modules with information on maintaining weight loss. 2. Participants in the SELF group will receive a wireless "smart" body weight scale and a wearable physical activity tracker, and daily text messages with tailored feedback to assist in weight loss maintenance. 3. Participants in the STEP group will be enrolled in an intervention that consists of 4 steps that are progressive and based on response to treatment. After 13 weeks at each step, participants who do not maintain a ≥5% weight loss or regain 2 percentage points of weight from the participants randomization value will move to a higher intensity step. Participants who maintain weight loss will stay at the same step.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, if you recently started or changed the dosage of a medication that can cause significant weight change, you may not be eligible to participate.
What data supports the effectiveness of the Stepped Care for Obesity treatment?
Research shows that personalized care planning, which includes understanding personal root causes and fostering positive provider-patient communication, can help patients with obesity make manageable changes to improve their health. Additionally, implementing clinical practice guidelines in primary care settings has been shown to improve the management of obesity by setting goals and assessing readiness for change.12345
What makes the STEP treatment for obesity unique compared to other treatments?
The STEP treatment, or Skills to Enhance Positivity, is unique because it focuses on enhancing positive skills and behaviors, which may differ from traditional obesity treatments that often emphasize diet and exercise alone. This approach could potentially address the psychological and behavioral aspects of obesity, offering a more holistic treatment option.678910
Research Team
Ariana M Chao, PhD, CRNP
Principal Investigator
Johns Hopkins University
Eligibility Criteria
This trial is for adults aged 18-70 with obesity, defined as a BMI of at least 30 or at least 27 with an obesity-related complication. Participants must have lost at least 5% of their initial weight during the first phase of the study, be able to exercise, own a smartphone and have home wireless access.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Run-in
16-week behavioral weight loss treatment with weekly-group lifestyle counseling and a partial meal replacement diet
Randomized Treatment
52-week randomized trial of 3 weight loss maintenance strategies: Usual Care, SELF, and STEP
Follow-up
Participants are monitored for weight maintenance and other health metrics after the treatment phase
Treatment Details
Interventions
- SELF
- STEP
- Usual care
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins University
Lead Sponsor
National Institute of Nursing Research (NINR)
Collaborator